Skip to content
10-Q

Quarterly Report

Clovis Oncology, Inc.

0001558370-22-017027

← back to feed
Filed
Nov 9, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 4, 2022 144.96M sh
Shares Diluted Q3 2022 · Sep 30, 2022 144.63M sh
Shares Diluted Q3 2022 · Sep 30, 2022 142.31M sh
Shares Diluted Q3 2022 · Sep 30, 2021 121.22M sh
Shares Diluted Q3 2022 · Sep 30, 2021 111.38M sh
Capex Q3 2022 · Sep 30, 2022 $197K
Capex Q3 2022 · Sep 30, 2021 $243K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$134.23M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$154.71M
Short Term Debt Q3 2022 · Sep 30, 2022 $438.32M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $58.32M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $143.43M
Stockholders Equity Q3 2022 · Sep 30, 2022 −$417.89M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$367.7M
Stockholders Equity Q3 2022 · Mar 31, 2022 −$303.31M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$278.84M
Stockholders Equity Q3 2022 · Sep 30, 2021 −$225.46M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$206.98M
Stockholders Equity Q3 2022 · Mar 31, 2021 −$221.04M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$158.75M
Current Liabilities Q3 2022 · Sep 30, 2022 $747.87M
Current Liabilities Q3 2022 · Dec 31, 2021 $125.21M
Total Liabilities Q3 2022 · Sep 30, 2022 $764.66M
Total Liabilities Q3 2022 · Dec 31, 2021 $751.67M
Current Assets Q3 2022 · Sep 30, 2022 $102.21M
Current Assets Q3 2022 · Dec 31, 2021 $198.09M
Total Assets Q3 2022 · Sep 30, 2022 $346.78M
Total Assets Q3 2022 · Dec 31, 2021 $472.83M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.39
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.32
Eps Diluted restated Q3 2022 · Sep 30, 2021 −$0.56
Eps Diluted restated Q3 2022 · Sep 30, 2021 −$1.80
Eps Basic Q3 2022 · Sep 30, 2022 −$0.39
Eps Basic Q3 2022 · Sep 30, 2022 −$1.32
Eps Basic Q3 2022 · Sep 30, 2021 −$0.56
Eps Basic Q3 2022 · Sep 30, 2021 −$1.80
Sga Expense Q3 2022 · Sep 30, 2022 $30.38M
Sga Expense Q3 2022 · Sep 30, 2022 $92.18M
Sga Expense Q3 2022 · Sep 30, 2021 $32.2M
Sga Expense Q3 2022 · Sep 30, 2021 $95.06M
Net Income Q3 2022 · Sep 30, 2022 −$56.01M
Net Income Q3 2022 · Sep 30, 2022 −$187.52M
Net Income Q3 2022 · Jun 30, 2022 −$71.33M
Net Income Q3 2022 · Mar 31, 2022 −$60.17M
Net Income Q3 2022 · Sep 30, 2021 −$67.41M
Net Income Q3 2022 · Sep 30, 2021 −$200.13M
Net Income Q3 2022 · Jun 30, 2021 −$66.45M
Net Income Q3 2022 · Mar 31, 2021 −$66.28M
Operating Income Q3 2022 · Sep 30, 2022 −$44.24M
Operating Income Q3 2022 · Sep 30, 2022 −$153.98M
Operating Income Q3 2022 · Sep 30, 2021 −$57.46M
Operating Income Q3 2022 · Sep 30, 2021 −$173.06M
Revenue Q3 2022 · Sep 30, 2022 $30.66M
Revenue Q3 2022 · Sep 30, 2022 $97.05M
Revenue Q3 2022 · Sep 30, 2021 $37.92M
Revenue Q3 2022 · Sep 30, 2021 $112.79M